Dr. Matthias Machacek is an engineer with 12 years of experience in applying quantitative methods in the life sciences – as an academic, drug developer and consultant.
Matthias joined Lixoft as a VP for modelling and pharmacology in 2014. In this role he is the key interface between Lixoft and end-users in pharmaceutical companies for training, consultancy and to advice Lixoft on the development of next generation modelling solutions. Matthias is also Managing Director at LYO-X, a unique company providing Systems Pharmacology services for the development of novel biopharmaceuticals. LYO-X is directly leveraging Lixoft’s software solutions to provide better services to the Biotech and Pharmaceutical industry.
Prior to joining Lixoft, Matthias was with the Novartis Modeling & Simulation group in Switzerland. At Novartis he initiated and managed the Engineering Cluster, a group dedicated to Systems Pharmacology and the support of eHealth solution development. Matthias is an active contributor to the Systems Pharmacology and eHealth community participating at conferences and acting as rapporteur for EU research programs. He has four patents and patent applications in the domain of modelling and eHealth.
Matthias holds a engineering degree from the ETH in Switzerland.